Fosfestrol

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Fosfestrol
Fosfestrol.svg
Clinical data
Trade names Honvan
AHFS/Drugs.com International Drug Names
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
ECHA InfoCard 100.007.573
Chemical and physical data
Formula C18H22O8P2
Molar mass 428.310 g/mol
3D model (JSmol)
 NYesY (what is this?)  (verify)

Fosfestrol (INN, BAN, JAN) (brand names Honvan, Difostilben, Fosfostilben, Fostrolin, Stilbol, Stilphostrol, Vagestrol, among others), also known as diethylstilbestrol diphosphate (USAN), abbreviated as DESDP or DESP, is a synthetic, nonsteroidal estrogen of the stilbestrol group that is or has been used in the treatment of prostate cancer.[1][2] It is a prodrug of diethylstilbestrol.[3] The drug has been marketed widely throughout the world, including in the United States, Canada, Europe, Hong Kong, and Mexico.[1]

See also[edit]

References[edit]

  1. ^ a b Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 332–. ISBN 978-3-88763-075-1. 
  2. ^ Shanbhag (1 January 2008). Pharmacology: Prep Manual for Undergraduates. Elsevier India. pp. 463–. ISBN 978-81-312-1153-3. 
  3. ^ Urotext (1 January 2001). Urotext-Luts: Urology. Urotext. pp. 386–. ISBN 978-1-903737-03-3.